30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Arie Belldegrun

Track

Insider profile

Currently holds positions in Arno Therapeutics Inc, Allogene Therapeutics Inc, Kite Pharma Inc and Urogen Pharma Ltd

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -15% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board Arno Therapeutics Inc March 1, 2008 -
Executive Chairman of the Board Allogene Therapeutics Inc Nov. 1, 2017 -
Executive Chairman of the Board, President, Chief Executive Officer, Founder Kite Pharma Inc March 1, 2014 -
Independent Chairman of the Board Urogen Pharma Ltd Dec. 1, 2012 -
Director Teva Pharmaceutical Industries Ltd Jan. 1, 2013 - Jan. 26, 2017
Executive Chairman of the Board, Interim President, Chief Executive Officer, Founder Kite Pharma Inc Dec. 1, 2013 - March 1, 2014
Executive Chairman of the Board, Founder Kite Pharma Inc None -
Director Capricor Therapeutics Inc Sept. 24, 2009 - Nov. 20, 2013
Arie Belldegrun's trades of Allogene Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-20 2024-05-16
B Purchase
73,492 -42.3%
436.47
US$1,259,588 		73,492 -42.3% 436.47 US$1,259,588
2024-05-20 2024-05-16
B Purchase
16,759 +21.8%
479.00
US$2,140,580 		16,759 +21.8% 479.00 US$2,140,580
2022-01-14 2022-01-12
B Purchase
47,089 -9.7%
265.94
US$2,418,468 		47,089 -9.7% 265.94 US$2,418,468
2020-06-04 2020-06-04
B Purchase
106,382 +6.3%
47.00
US$4,999,954 		106,382 +6.3% 47.00 US$4,999,954
2020-06-04 2020-06-04
B Purchase
40,000 +inf%
47.00
US$1,880,000 		40,000 +inf% 47.00 US$1,880,000